Vivus’s Weight-Loss Pill Covered by Insurers 30% of the Time

Vivus Inc.’s obesity drug Qsymia was covered by health insurers more often than anticipated in its first week on the market, which may help drive sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.